Arete Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-469
Closed -$317K 497
2025
Q4
$317K Sell
469
-23
-5% -$15.7K 0.02% 572
2025
Q3
$316K Sell
492
-13
-3% -$7.89K 0.02% 580
2025
Q2
$271K Sell
505
-63
-11% -$30.1K 0.02% 595
2025
Q1
$239K Buy
568
+10
+2% +$4.34K 0.02% 614
2024
Q4
$231K Buy
558
+17
+3% +$7.46K 0.02% 651
2024
Q3
$272K Sell
541
-8,030
-94% -$3.9M 0.02% 549
2024
Q2
$4.17M Buy
+8,571
New +$4.3M 0.34% 62
2024
Q1
Sell
-8,478
Closed -$4.71M 522
2023
Q4
$4.71M Buy
8,478
+2
+0% +$939 0.36% 62
2023
Q3
$3.71M Buy
8,476
+47
+0.6% +$23.4K 0.64% 28
2023
Q2
$4.23M Buy
8,429
+6,582
+356% +$3.15M 0.37% 59
2023
Q1
$924K Buy
1,847
+73
+4% +$34.9K 0.08% 230
2022
Q4
$724M Sell
1,774
-46
-3% -$17.9K 0.06% 261
2022
Q3
$593K Buy
+1,820
New +$669K 0.06% 269
2022
Q2
Sell
-1,444
Closed -$790K 504
2022
Q1
$790K Sell
1,444
-77
-5% -$40.5K 0.07% 209
2021
Q4
$1M Buy
+1,521
New +$955K 0.09% 189
2021
Q3
Sell
-412
Closed -$206K 431
2021
Q2
$206K Sell
412
-1
-0.2% -$552 0.03% 332
2021
Q1
$202K Sell
413
-20
-5% -$10K 0.03% 398
2020
Q4
$216K Buy
+433
New +$194K 0.03% 368
2018
Q4
Sell
-992
Closed -$248K 387
2018
Q3
$248K Buy
+992
New +$241K 0.06% 304

Other funds holding IDXX

Arete Wealth Advisors's IDXX Position: Q1 2026 in Review

Arete Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 469 shares — an estimated $317K sold.

Arete Wealth Advisors first reported a position in IDXX in Q3 2018 and held it in 19 quarters. The position peaked at $724M in Q4 2022. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Arete Wealth Advisors reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Arete Wealth Advisors sold 469 Idexx Laboratories shares in Q1 2026, an estimated $317K.
  • Arete Wealth Advisors first reported a position in Idexx Laboratories in Q3 2018 and held it in 19 quarters.
  • Arete Wealth Advisors's Idexx Laboratories position peaked at $724M in Q4 2022.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.